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Nitric oxide (NO) is an atypical neurotransmitter synthesized by the enzyme nitric oxide 
synthase (NOS) during many stages of the Xenopus laevis life cycle. This research investigates 
whether the gas NO is involved in axon guidance, the neurodevelopmental process in which 
axons travel through the brain to their appropriate target locations to form functional neural 
circuitry. Through immunocytochemistry and direct labeling of the NO gas with a fluorescent 
dye, we have found that NOS expression corresponds spatiotemporally with the beginning of 
retinal axon innervation of the optic tectum in X. laevis. Our function-blocking studies in which 
NO is chemically inhibited suggest that NO may be necessary for correct pathfinding and 
targeting, evidenced by qualitative widening of the optic tract and aberrant target innervation. 
 
Abbreviations:  NO – nitric oxide, NOS – nitric oxide synthase, RGC – retinal ganglion cell, OT 
– optic tectum, L-NAME – L-nitro arginine methyl ester 
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Introduction
          Axon  guidance  refers  to  how  axons 
pathfind,  or  travel,  from  one  location  in  the 
nervous  system  to  another.  Proper  and 
appropriate  axon  guidance  in  a  developing 
organism  is  necessary  for  the  formation  of 
neural circuits and, consequently, the transfer of 
information throughout the nervous system. The 
retinotectal  system,  which  involves  the  axons 
that travel from the retina to the optic tectum, is 
a  model  researchers  use  to  investigate  the 
mechanisms underlying axon guidance. Xenopus 
laevis, the African clawed frog, is an appropriate 
model  organism  to  use  in  the  study  of 
retinotectal  axon  guidance  because  it  produces 
hundreds  of  embryos  per  mating  round, 
progresses  rapidly  through  different 
developmental stages, and is sufficiently large to 
allow for manipulation, microsurgery, dissection 
and  axon  tract  labeling  (Chien  and  Harris, 
1994).  Furthermore,  retinal  axon  morphology 
and  progression  is  well-documented  and 
understood in X. laevis, which allows inhibition 
and over-expression studies to be performed as 
the resulting phenotypes can be compared to a 
known standard of normal axon guidance (Chien 
and Harris, 1994). 
  The  retinal  ganglion  cell  (RGC)  axons 
that  ultimately  form  the  circuitry  of  the 
retinotectal system during development first exit 
the eye, then enter the brain at the location of the 
ventral diencephalon, cross at the optic chiasm 
to enter the contralateral optic tract, and travel 
along  the  tract,  turning  caudally  towards  the 
optic tectum (OT). The OT is the location in X. 
laevis where visual input from the retina is sent 
(Harris and Holt, 1990). These axons travel at a 
relatively  uniform  speed  and  only  slow  down 
once  they  near  the  optic  tectum,  the  target 
location  where  arborization,  or  unbundling  of 
the  axon  tract  and  innervation  of  the  target 
region,  occurs  (reviewed  in  Harris  and  Holt, 
1990). When the embryos are housed at 22ºC, it 
takes  the  axons  13  hours  to  travel  the 
approximately half millimeter distance from the 
chiasm to the optic tectum (Harris et al., 1985).  Page 2 of 12 
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  A  number  of  molecules,  termed  axon- 
guidance  cues,  function  to  help  the  axons 
migrate along the appropriate, stereotyped path 
(Harris and Holt, 1990). A subset of these axon 
guidance  cues  serve  to  assist  with  target 
recognition; these cues instruct the RGC axons 
to recognize the target region, reduce migration 
speed, and stop advancing, and arborize once the 
optic tectum is reached (Harris and Holt, 1990).  
  Although  many  axon  guidance  cues 
have been elucidated, not much is known about 
the cues that guide X. laevis RGC axons from 
the  retina  to  the  optic  tectum.  One  currently 
being investigated by researchers is nitric oxide 
(NO),  a  gaseous  free  radical  classified  as  a 
neurotransmitter.  Unlike  typical  neuro-
transmitters,  however,  NO  is  not  stored  in 
vesicles (Bruning and Mayer, 1996). In humans, 
NO has a variety of different functions, from the 
regulation  of  blood  flow  to  acting  as  the 
response  to  action  potentials  in  the  thalamus 
(reviewed  in  Vincent,  2010).  Although  axon 
growth  cones  in  snail  neurons  lengthen  in 
response  to  NO  donors  (Van  Wagenen  and 
Rehder, 1999), the role of NO in axon guidance 
has yet to be firmly elucidated.  
  In culture, NO has been shown to act as 
a repulsive cue on dorsal root ganglion cell axon 
growth  cones  that  are  plated  on  a  laminin 
substrate,  but  as  an  attractive  cue  on  growth 
cones that are plated on an L1 substrate (Tojima 
et  al.,  2009).  Given  that  numerous  different 
extracellular  matrix  and  substrate  proteins  are 
present in vivo, it is unknown whether NO will 
act  as  a  repulsive  cue  or  an  attractive  cue,  or 
possibly  both  depending  on  concentration  or 
presence of varying extracellular matrix and cell 
adhesion  molecules,  in  the  actual  X.  laevis 
embryo. Researchers have deduced that NO is 
necessary  for  the  refinement  of  established 
axonal projections in the frog, but this is a later 
stage of neural development preceded by axon 
guidance  (Wu  et  al.,  2001;  Cline  and 
Constantine-Paton, 1990).  
  Current  research  on  the  expression  of 
nitric  oxide  synthase  (NOS),  the  enzyme 
responsible for the production of NO, has found 
NOS  positive  cells  in  the  optic  tectum  of  the 
chick,  fish,  and  frog  (reviewed  in  Girladi-
Guimardes  et  al.,  2007).  In  teleost  fish,  NOS 
immunoreactivity  was  found  in  the  retinal 
ganglion cells and could be traced along these 
axons to the optic tectum (Gaikwad, 2009). The 
precise timing of the expression of NOS in X. 
laevis,  however,  is  disputed  in  the  literature. 
Some  researchers  have  suggested  that 
expression does not begin until premetamorphic 
stage  46  (Lopez  and  Gonzalez,  2002),  while 
others propose that NOS protein is first made at 
stage  35-36,  when  axons  turn  caudally  to 
reorient themselves towards the tectum (Cogen 
and  Cohen-Cory,  2000).  Consequently,  the 
timing of onset of expression of NOS needs to 
be defined and clarified. As  stated  previously, 
the majority of the data on the role of NO with 
axons  is  in  regards  to  the  refinement  of 
established  axonal  connections,  not  on  the 
formation  of  axonal  connections  during 
development.  In  the  presence  of  NO  donors, 
branches,  which  are  projections  off  of  the 
primary  axon  tract,  are  added  to  established 
axon  tracts,  but  in  the  presence  of  NOS 
inhibitors, there is an increase in the length of 
individual axon branches, but no net increase in 
the  number  of  branches  (Cogen  and  Cohen-
Cory,  2000).  In  late  stages  (55-60,  when  the 
majority  of  the  organisms  are  froglets)  of  X. 
laevis  RGC  axon  explants  in  culture,  the 
application  of  an  NO  donor  led  to  reduced 
motility or complete growth cone collapse in the 
majority of the growth cones analyzed (Renteria 
and  Constantine-Paton,  1999).  However,  this 
cannot be definitively extrapolated to the growth 
cones of RGCs as they travel from the retina to 
the  optic  tectum,  since  these  RGCs  are  from 
earlier stage embryos and refinement is not yet 
occurring,  because  the  axons  have  not  yet 
reached  their  final  destination  in  the  optic 
tectum. 
  In the chick visual system, expression of 
NOS is temporally linked to axon innervation of 
the  optic  tectum,  so  it  is  possible  that  nitric 
oxide plays a role in keeping axons on the path 
to  the  optic  tectum  (Williams  et  al.,  1994). 
Furthermore, NO has been found to slow neurite 
outgrowth of Helisoma B5 neurons (Trimm and 
Rehder, 2004); this slowing-down phenomenon 
is  necessary  once  the  axons  begin  to  near  the 
target  region  so  that  the  axons  innervate  the 
appropriate area and a functioning neural circuit 
is formed. Based on these functions of NO in 
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an axon guidance cue in RGC axon guidance in 
X. laevis.  
  This research is looking to address the 
hypothesis  that  NO  plays  a  role  in  axon 
pathfinding  along  the  optic  tract  to  the  optic 
tectum. We hypothesized that if NO does indeed 
have  a  function  in  this  portion  of  retinotectal 
circuit  formation,  NOS  and  NO  gas  are  likely 
expressed in the optic tectum and that inhibiting 
NO  will  cause  axon  guidance  defects.  The 
embryos  examined  were  stage  35-36  embryos, 
when  the  axons  reach  the  middle  of  the  optic 
tract and turn caudally towards the tectum, stage 
37-38 embryos, when the first axons reach the 
optic  tectum,  and  stage  39-40  embryos,  when 
the  majority  of  axons  have  reached  the  optic 
tectum and have begun the arborization process 
(Chien and Harris, 1994). 
  It is important to study axon guidance as 
aberrant  axon  guidance  is  implicated  in  a 
number  of  diseases  and  neurodevelopmental 
pathologies. For example, the over-expression in 
adults  of  semaphorins,  netrins  and  slits, 
established  axon  guidance  molecules  that 
normally  govern  the  development  of  neuronal 
circuits, could possibly lead to the destruction of 
functioning  neural  circuits  in  Amyotrophic 
Lateral Sclerosis (Schmidt et al., 2009). Given 
that NO plays many important roles in the adult 
human  nervous  system,  perhaps  understanding 
its  role  in  the  development  of  the  nervous 
system  during  axon  guidance  will  allow  for  a 
better of understanding of its myriad functions, 
both in normal and pathological states. 
 
Material and Methods 
  All  reagents  are  from  Sigma-Aldrich, 
Saint Louis, MO, unless otherwise noted. 
X. laevis embryo fixation 
  X.  laevis  embryos  were  obtained  from 
in-house natural matings with Human Chorionic 
Gonadotropin (HCG)-injected adult females. All 
of the protocols detailed in this manuscript were 
IACUC  approved  carried  out  according  to  the 
Haverford  College  IACUC  guidelines.  The 
embryos  were  then  grown  at  either  16°C  or 
22°C to regulate development, as the embryos 
mature  faster  at  higher  temperatures.  Embryos 
of  the  desired  developmental  stage  (staging 
according  to  observational  criteria  established 
by Nieuwkoop and Faber, 1956) were fixed in 
MEMFA  (8:1:1  ratio  of  ddH2O,  37% 
formaldehyde, and 10X MEM salts) or Dent’s 
(20%  Dimethyl  Sulfoxide  (DMSO)  and  80% 
MeOH)  fixatives  for  anti-NOS  and  anti-
neurofilament  (anti-NF)  immunocytochemistry, 
respectively.  Different  antibodies  require 
different fixation conditions for optimal results, 
and this must be worked out for each antibody in 
question (Sive et al., 2000). Consequently, the 
embryos  were  fixed  in  different  solutions 
depending  on  the  antibody  staining  procedure 
that  was  to  follow  dissection,  as  NF  works 
optimally  in  Dent’s  fixative,  while  anti-NOS 
works  optimally  in  MEMFA  fixative.  Fixed 
embryos were stored in 100% EtOH (MEMFA 
fixative) or 100% EtOH (Dent’s fixative) at -20° 
C until use.  
 
X. laevis embryo brain dissection 
  Petri dishes were coated with a solution 
of  1%  agar  prepared  in  1XMarc’s  Modified 
Ringer’s solution to create a dissecting dish. The 
agarose  mixture  was  allowed  to  solidify  to 
provide  a  supportive  surface  on  which  to  pin 
down  and  dissect  the  embryos.  Using  no.  5 
watchmaker’s  forceps,  halved  micro-pins  were 
inserted through the embryo into the agar in two 
locations:  directly  behind  the  eye  and  in  the 
middle of the tail. This kept the embryo in place 
during  the  dissection  process.  Using  an  insect 
pin, the skin covering the eye was gently peeled 
off  and  removed  using  the  watchmaker’s 
forceps.    Next,  the  insect  pin  was  used  to 
separate  the  brain  tissue  from  the  rest  of  the 
embryo.  The  brain  tissue  was  then  used 
immediately  for  immunocytochemical  analyses 
or stored in 100% EtOH at -20°C for later use. 
 
Anti-NOS immunocytochemistry 
  10-15  MEMFA-fixed  brain  tissue 
samples  each  dissected  from  the  appropriate 
stage (35, 37, 40) whole embryo first underwent 
a  series  of  washes  in  TBS  buffer  and  0.3%-
Triton-X-TBS to rehydrate and permeabilize the 
tissue.  Next,  the  brain  tissue  samples  were 
incubated  in  20%  Fetal  Calf  Serum  (FCS) 
diluted  in  1X  TBS  to  prevent  non-specific 
binding  of  the  antibody.  After  blocking,  the 
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1:500  dilution  of  anti-NOS1  primary  antibody 
(Santa  Cruz  Biotechnology,  Santa  Cruz,  CA) 
prepared in 20% FCS. A set of control embryos 
was incubated in the blocking solution without 
the primary antibody to ensure that the staining 
seen after the substrate reaction was not merely 
non-specific  background  binding.  After  TBS 
buffer washes, the samples were incubated in a 
1:100  dilution  of  goat  anti-rabbit  alkaline 
phosphatase tagged secondary antibody (Sigma-
Aldrich, Saint Louis, MO).  Finally, a substrate 
reaction was performed to localize the presence 
of the NOS antibody-tagged protein by adding 
the  alkaline  phosphatase  BCIP/NBT  substrate 
(SIGMAFAST
TM  BCIP
®/NBT,  Sigma-Aldrich, 
Saint  Louis,  MO)  to  the  brain  tissue  samples. 
The  brain  tissue  samples  were  allowed  to 
incubate  in  the  substrate  solution  for 
approximately  5  minutes  or  until  the  blue 
localization color appeared. Samples were then 
visualized  and  imaged  using  a  Nikon  DXM 
microscope and NIS elements imaging software.  
 
DAF-FM  (4-Amino-5-methylamino-2’,7’-
difluoroescin) diacetate labeling of NO gas 
  The  diaminoflourescin  DAF-FM  is  a 
reagent  that  fluorescently  labels  and  localizes 
NO  (Kojima  et  al.,  1999).  The  DAF-FM 
diacetate effectively labels the NO gas because 
it  is  a  dye  that  emits  an  increased  amount  of 
fluorescence after it reacts with an intermediate 
of  the  spontaneous  reaction  of  NO  to  NO2- 
(Sheng et al., 2005; Kojima et al., 1999). DAF-
FM  diacetate  (Molecular  Probes,  Invitrogen, 
Carlsbad,  CA)  was  diluted  to  a  1mM 
concentration  in  DMSO.  The  experimental 
embryos    (approximately  10-15  embryos  per 
stage) were bathed in a 5µM solution of DAF-
FM  prepared  in  0.1X  MMR  for  30  minutes, 
while  control  embryos  (approximately  5-10 
embryos per stage) were bathed in 0.1X MMR 
for 30 minutes so that the autofluorescence of 
the embryos could be examined. After the bath 
application, the embryos were fixed in MEMFA 
fixative  as  detailed  above.  For  image 
acquisition,  the  FITC/GFP  filter  on  a  Nikon 
DXM  camera-equipped  microscope  and  NIS 
elements  imaging  software  were  used.  After 
images of the whole embryo were acquired, the 
brain tissue was dissected and images of isolated 
brain  tissue  were  subsequently  taken.  An 
outlining  procedure  was  performed  in  Adobe 
Photoshop to show that the embryos that did not 
fluoresce, and were subsequently not seen in the 
captured images, were actually present under the 
microscope.  The  control  images  were 
overexposed  using  the  auto  contrast  feature, 
which  picks  up  miniscule  amounts  of 
fluorescence,  allowing  a  rough  outline  of  the 
embryo to be seen. This overexposed image was 
then traced using the paintbrush feature and the 
tracing was copied to a non-overexposed copy 
of  the  original  image,  showing  where  the 
embryo would have been located. Tracing of the 
experimental samples was done for consistency, 
though  the  overexposure  was  not  performed 
when  the  embryo  could  be  visualized  clearly 
without doing so. 
 
L-NAME (L-nitro arginine methyl ester) NO 
inhibition studies 
  L-NAME  (Sigma-Aldrich,  Saint  Louis, 
MO) is a chemical inhibitor of NO production. 
Its  structure  is  markedly  similar  to  that  of  L-
arginine, the starting material for NO synthesis. 
Consequently,  L-NAME  exerts  its  effects  by 
competing  with  L-arginine,  which  is  normally 
converted  to  L-citrulline  and  NO  by  NOS 
(Knowles  et  al.,  1989).  For  the  inhibition 
studies,  approximately  20-30  stage  30-31 
embryos were incubated in a solution of either 
5µM L-NAME prepared in 0.1X MMR or pure 
0.1X MMR, the latter serving as a control. The 
embryos  were  allowed  to  develop  until  they 
reached stage 39-40, when the majority of the 
axons  have  reached  their  target  of  the  optic 
tectum.  Retinal  axons  were  then  labeled  using 
the anti-NF labeling method described below.  
 
Anti-NF immunocytochemistry for L-NAME 
inhibition studies 
  Anti-NF  labeling  is  a  means  to  label 
axons  that  is  significantly  less  technically 
demanding  than  other  procedures,  such  as 
horseradish  peroxidase  or  fluorescent 
intercalation  labeling.  Consequently,  anti-NF 
labeling is used to increase sample size or when 
timing  prohibits  HRP  labeling,  which  must  be 
done  on  live  tissue.  It  is  important  to  note, 
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label  retinal  axons,  especially  near  the  optic 
tectum.  Other  axons  also  express  the 
cytoskeletal neurofilament protein to which the 
antibody binds; the tightly bound retinal axons 
of the optic tract allow for clear labeling in that 
area, but once the retinal axons begin to reach 
the  optic  tectum  they  begin  to  spread  out  and 
labeling becomes less specific for retinal axons. 
Consequently, HRP anterograde labeling is still 
the  preferred  method  for  retinal  axon  tract 
labeling.  Recently,  however,  the  protocol  was 
optimized  for  labeling  of  retinal  axons  by 
incubating the tissue in a lower concentration of 
primary antibody (1:1000 vs. 1:100 dilution) for 
a  longer  time  (for  2  days  as  opposed  to 
overnight)  and  including  more  washes  (6  or  7 
washes  as  opposed  to  4  washes);  this  allows 
more efficient labeling of the retinal axons near 
the  optic  tectum  and  reduces  non-specific 
background  in  that  region.  Dissected  Dent’s 
fixed  brain  tissue  samples  underwent  a 
procedure similar to that described above for the 
anti-NOS  immunocytochemistry  labeled 
samples.  The  primary  antibody  used  was  a 
1:1000 dilution of anti-NF antibody (Invitrogen, 
Carlsbad, CA) and the secondary antibody used 
was a 1:100 dilution of goat anti-rabbit antibody 
(Sigma-Aldrich, Saint Louis, MO). Finally, the 
brain  tissue  was  imaged  using  a  NikonDXM 
camera-equipped microscope and NIS Elements 
imaging  software.  On  Adobe  Photoshop,  the 
width of the RGC tract was measured using the 
ruler tool. The optic tract width measurements 
for  the  treated  and  non-treated  samples  were 
averaged,  and  the  standard  deviation  was 
calculated using Microsoft Excel. A non-paired, 
two-tailed  Student’s  t-test  was  also  performed 
using Microsoft Excel. 
 
Results 
NOS Immunocytochemistry 
  In  stage  37  X.    laevis  NOS  antibody-
incubated  brain  tissue,  there  is  blue  colored 
staining, which indicates NOS expression in the 
area in and around the optic tectum (Figure 1C, 
I).  The  tectum  is  identified  based  on 
morphological  landmarks  given  in  Chien  and 
Harris  (1994);  the  small  raised  bump  in  the 
midbrain region is where the tectum is located in 
the mid 30s to mid 40s developmental stages. In 
the control samples, which were not treated with 
the primary antibody, there is no localization of 
NOS staining in or around the OT (Figure 1D, 
J). In brain tissue dissected from stage 35 and 
stage  40  embryos;  however,  the  experimental 
brain  tissue  incubated  in  the  primary  antibody 
does  not  appear  markedly  different  from  the 
negative control brain tissue (Figure 1A, B, E, F, 
G, H, K, L). In some of the samples, both in the 
experimental  and  control  tissue,  there  is  an 
accumulation of pigment cells in the tectal area, 
which must be differentiated from true staining. 
There is no localization of blue staining in the 
OT as in the stage 37 brain tissue, which leads to 
the conclusion that the NOS synthase protein is 
not  expressed  in  stage  35  and  stage  40  brain 
tissue. In sum, NOS is expressed near the tectum 
in  stage  37,  but  not  stage  35  or  40  X.  laevis 
embryos. 
 
NO Expression Studies (DAF-FM Labeling) 
In  67%  (n=6)  of  stage  35  whole 
embryos  incubated  in  the  DAF-FM  diacetate 
solution,  green  fluorescence,  which  signifies 
presence  of  the  NO  gas,  is  observed,  but  the 
fluorescence  does  not  extend  fully  into  the 
dorsal region where the brain is located (Figure 
2A).  In  33%  (n=3)  of  stage  35  embryos, 
however, there is little to no expression where 
the  eye  is  located.  For  the  stage  37  embryos 
treated  with  DAF-FM  diacetate,  all  of  the 
embryos (n=6) examined show NO expression 
in the area around the eye, similar to the stage 
35  embryos.  In  stage  37  embryos,  the  NO 
expression does not extend completely into the 
dorsal region where the brain is located (Figure 
2B).  In  stage  40  embryos,  all  samples  (n=7) 
have  NO  expression  around  the  eye  region 
(Figure 2D). In these samples there appears to 
be  a  complete  absence  of  fluorescence  in  the 
regions where the brain is located, whereas in 
the stage 35 and 37 samples, the fluorescence in 
that region is dim but not non-existent (Figure 
2C).  Overall,  NO  gas  is  expressed  near 
developing  neural  structures  in  all  embryonic 
stages examined (Figure 2D). 
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In brain tissue dissected from stage 35 
embryos, the fluorescence is only slightly more 
intense in the treated samples (n=13) than in the  
control  samples  (n=7)  (Figure  3A,B). 
Consequently, the level of NO in stage 35 brain 
tissue is likely relatively low, if present at all. In 
the stage 37 brain tissue, however, the intensity 
of  fluorescence  is  markedly  increased  in  the 
treated  samples  (n=9)  compared  to  the  control 
samples (n=4). In some of the stage 37 samples 
the  NO  expression  is  concentrated  throughout 
the brain tissue (n=3); in other samples (n=6), 
however, the expression is more localized in the 
region just above the notochord and posterior to 
the retinal axon tract (Figure 3C). In the brain 
tissue  isolated  from  stage  40  embryos,  the 
samples incubated with the DAF-FM diacetate 
(n=8)  do  not  differ  in  fluorescence  intensity 
from the control samples (n=4). This leads to the 
conclusion that NO is not present at appreciable 
levels  in  the  brain  tissue  of  stage  40  embryos 
(Figure 3E,F). In sum, NO gas is expressed in 
brain tissue from stage 37 embryos, but not in 
brain tissue from stage 35 or 40 embryos (Figure 
2G). 
 
L-NAME Inhibition Studies 
  Following  incubation  in  either  the  NO 
inhibitory solution or the control solution, anti-
NF immunocytochemistry was performed on the 
brain  tissue  samples,  leading  to  successful 
labeling of the optic tract. This labeling of the 
optic  tract  is  necessary  to  observe  phenotypic 
differences between the drug-treated and control 
samples. The two main defects observed in the 
brain  tissue  from  L-NAME  treated  embryos 
(n=7) are premature widening of the optic tract 
and targeting errors. Compared to the embryos 
which were incubated in 0.1X MMR (n=5), the  
   
Figure 1: NOS is expressed in the optic tectal region of stage 37 brain tissue. Experimental denotes primary antibody 
added, control denotes no primary antibody. In stage 35 experimental (A: whole brain; G: close up of tectal region) there is no 
defined blue (NOS) staining. The control brain tissue (B: whole embryo; H: tectal region) is clean and has low background. In 
stage 37 experimental, there is a defined blue region (NOS) in and around the optic tectum (C: whole embryo, see red arrows; 
I: tectal region). Stage 37 control brain tissue (D: whole embryo; J: tectal region) is clean and has low background. Staining is 
observed in stage 40 experimental (E: whole brain; K: tectal close up), but is likely only background and not NOS expression, 
as it is similar to background staining in control (F: whole brain; L: tectal region). All images 60X. 
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Figure 2: Nitric oxide gas is expressed in stage 35-40 whole embryos. Experimental denotes DAF-FM diacetate dye 
added, control denotes no dye added. In the majority (67%) of the stage 35 whole embryos, NO is expressed in the region 
surrounding the eye and where the brain is located, but with a lesser intensity in the brain region; A is a representative 
image. All stage 37 whole embryos examined have expression of NO surrounding the eye and into the brain region, but 
lesser intensity in brain region; B is a representative image. In stage 40 embryos, all have expression in the region 
surrounding the eye, but the staining does not extend into the region where the brain is located; C is a representative image. 
D shows percentage of DAF-FM treated embryos that express NO in eye region. All images 80X. 
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FIGURE 3 
Figure 3: NO gas is expressed in stage 37 brain tissue: Experimental denotes DAF-FM diacetate dye added, control 
denotes no dye added. In stage 35 and stage 40 there is not a significant observable difference between the experimental 
(A, E) and control embryos (B, F). In stage 37, the experimental brain tissue (C) glows green (NO+) while the control 
(D) does not. The stage 37 expression is concentrated in the region above the notochord posterior to where the retinal 
axon tract would be located. G is a graphic representation of the pattern of NO gas expression in the developmental 
stages examined. All Images 115X. 
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optic  tract  of  the  L-NAME  embryos  appears 
qualitatively  wider  in  at  least  2  out  of  the  7 
samples  (Figure  4A).  From  this  data,  we 
conclude  that  NO  appears  to  be  required  for 
normal  RGC  axon  guidance  along  the  optic 
tract.  A  paired,  two-tailed  student’s  t-test, 
however, gave a non-significant p value of 0.077 
(Figure 4B). 
 
Discussion 
  The procedure to determine whether a 
particular molecule is an axon guidance cue is  
two-fold; data must be obtained about both the 
expression  and  function  of  the  molecule  in 
question. In order for a molecule to be classified 
as  an  axon  guidance  cue,  it  must  have  a 
spatiotemporal pattern of expression that agrees 
with  the  developmental  time  period  and  the 
location in which the axons are extending. In the 
case of retinal axon pathfinding from the ventral 
diencephalon to the optic tectum, this means that 
the putative cue must be present in at least some 
of the developmental time period between stage 
32 and stage 40. Furthermore, the cue must be 
expressed in or near the region where the retinal 
axons are extending. Given that NOS and NO 
are  likely  expressed  in  stage  37  of  X.  laevis 
development, when the first retinal axons have 
begun  to  reach  the  optic  tectum,  NO  satisfies 
this first spatiotemporal expression requirement 
for classification as an axon guidance molecule. 
 
 
 
   
L-NAME 
 
Control 
     L-NAME               CONTROL 
FIGURE 4 
    p=0.077 
A.  B. 
Figure 4: Schematic and quantification of observed axon extension phenotype upon treatment with L-
NAME. A. In the L-NAME treated brain tissue, there is earlier arborization of the optic tract than observed in 
the controls, denoted by the red arrows. Arborization signifies targeting, so the axons are targeting more 
ventrally in the L-NAME treated sample than in the control. B. There is also qualitative widening of the optic 
tract as it pathfinds over the neuroepithelium in the treated samples compared to the control samples, though the 
change in width is not statistically significant (p value of 0.077, two-tailed paired Student’s t-test).  
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NOS Expression Studies   
  We  found  that  NOS,  the  enzyme 
responsible for NO production, is expressed in 
the optic tectal region in brain tissue from stage 
37 Xenopus embryos, but not in the brain tissue 
from  stage  35  or  40  embryos.  This  clarifies 
conflicting data from previous NOS expression 
studies, which reported expression beginning in 
such  varying  developmental  time  periods  as 
stage 35-36 to stage 46 (Cogen and Cohen-Cory, 
2000;  Lopez  and  Gonzalez,  2002).  The 
spatiotemporal expression in stage 37 suggests 
that  NOS  is  likely  involved  more  so  in  the 
inception  of  axon  targeting,  which  begins  in 
stage 37-38 of development, rather than in the 
earlier pathfinding processes that occur in stage 
35-36 embryos. 
    
NO Expression   
  An  important  step  in  our  process  to 
determine that NO indeed satisfied the appropri-
ate spatiotemporal expression characteristic of a 
guidance cue was to assay for the presence of 
the NO gas. Although our immunocytochemis-
try data showed that the enzyme responsible for 
the  production  of  NO  was  present,  it  did  not 
provide  us  with  direct  information  about  the 
presence  of  the  NO  gas  itself.  With  many 
enzymes, it is possible that the product may be 
transported away from the site of synthesis. This 
is  especially  an  issue  when  the  products  are 
gases,  which  are  often  diffusible  in  nature, 
although  they  could  be  held  in  place  to  some 
degree  by  the  presence  of  an  extracellular 
matrix.  From  the  DAF-FM  diacetate  staining 
data, we can conclude that although the NO gas 
does diffuse away from the site of synthesis (the 
tectal region) to some degree, it remains in the 
brain tissue of stage 37 X. laevis embryos.  
  In  some  of  the  stage  37  samples  the 
NO gas is located throughout the entirety of the 
brain  tissue  (Figure  3C),  however,  in  the 
majority of others the gas is more localized to 
the ventral region and posterior to the path of 
axon travel (image not shown). These different 
expression  patterns  suggest  different  possible 
functions for NO in retinal axon guidance. If it 
is indeed expressed throughout the brain tissue, 
perhaps it functions to keep the axons traveling 
throughout the brain until they reach the optic 
tectum,  where  another  guidance  cue  signals 
them  to  stop  traveling  and  innervate  the  optic 
tectum. When varying concentrations of an NO 
donor were applied to the growth cones of snail 
axons from B5 neurons in culture, the response 
varied  depending  on  the  amount  of  donor 
applied.  With  low  concentration  of  the  donor, 
neurite  extension  begins  to  slow,  with  an 
intermediate  concentration,  neurite  outgrowth 
stops,  and  with  a  high  concentration,  growth 
cones collapse. Given the expression of NO in 
stage  37  embryos,  when  the  axons  must 
recognize and innervate the tectum, it is possible 
that  NO  is  acting  as  a  “slow-down  and  stop” 
signal  as  it  does  in  snail  axons  (Trimm  and 
Rehder, 2004). Although the NO gas is not only 
expressed in the optic tectum, perhaps it is the 
contact  with  the  NO  that  causes  the  axons  to 
stop extending, which subsequently signals they 
should  innervate  the  region  they  are 
approaching.  The  optic  tectum  may  be  the 
source  of  another  guidance  cue,  but  for  the 
axons to fully respond to this other cue at the 
optic  tectum,  they  might  need  to  be  first 
sufficiently slowed by NO.  
  Netrin-1  and  Engrailed  are  molecules 
expressed  in  the  optic  tectum  during  axon 
pathfinding  or  targeting  (reviewed  in  Mann  et 
al.,  2004;  Wizenmann  et  al.,  2009);  these  are 
hypothetical  guidance  cues  to  which  NO  may 
allow the axons to respond. Another possibility 
for the function of NO that corresponds with the 
ventral and posterior staining pattern is that NO 
is acting as a repulsive guidance cue. The gas is 
preventing  the  axons  from  migrating  into  the 
area more ventrally than is appropriate, keeping 
them on the appropriate track to the tectum. In 
fact, NO was found in some instances to act as a 
repulsive  axon  guidance  cue  in  dorsal  root 
ganglion  cell  axons  in  chick  (Tojima  et  al., 
2009).  It  is  important  to  recognize,  however, 
that we cannot make the direct conclusion from 
this  data  that  NO  will  serve  the  exact  same 
purpose in X. laevis retinal axon guidance.  
 
NO Inhibition Studies 
  The  functional  studies  allow  us  to 
make  more  definitive  hypotheses  as  to  the 
specific  role  of  NOS  and  NO  in  retinal  axon 
guidance  in  Xenopus  by  showing  us  the 
morphological  defects  when  NO  is  inhibited. 
Although the widening of the optic tract in the 
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L-NAME  treated  samples  is  not  statistically 
significant,  on  examination  of  some  of  the 
samples,  the  optic  tract  does  in  fact  appear 
considerably wider. These observations suggest 
that further quantitative analyses be performed 
on a larger number of brain tissue samples that 
is  more  consistently  labeled  to  see  if  there  is 
indeed a significant widening of the optic tract. 
The  qualitative  widening  of  the  optic  tract 
observed in the L-NAME treated embryos could 
be due in part to the presence of NO throughout 
the  brain  tissue  keeping  the  axons  tightly 
bundled together.  
  In  fact,  the  neural  cell  adhesion 
molecule  (NCAM),  which  is  known  to  play  a 
role  in  neurite  outgrowth,  has  been  found  to 
exert its effects through interaction with the NO-
cGMP signaling cascade. NCAM is suggested to 
function in neurite outgrowth via the production 
of cGMP to activate protein kinase G; NCAM 
increases  the  concentration  of  cGMP  by 
activating soluble guanylyl cyclase through NO 
(Ditlevsen et al., 2007). Perhaps the presence of 
NO throughout the brain tissue is necessary for 
NCAM to function properly and keep the tract 
tightly bundled. The targeting errors, evidenced 
by the premature arborization and innervation of 
the  retinal  axons  in  the  L-NAME  treated 
samples,  suggest  that  NO  is  required  in  some 
manner for the axons to reach and appropriately 
recognize the optic tectum as the location to stop 
advancing. If NO is not interacting appropriately 
with  NCAM,  this  could  possibly  lead  to  the 
failure  of  the  axons  to  advance  to  the  tectum. 
This lack of advancement could then aberrantly 
signal to the axons that they had reached their 
target and should arborize, which would account 
for  the  inappropriate  innervation/arborization 
phenotype  observed.  NO-cGMP  staining  has 
been found to be characteristic of migrating gut 
cells  in  the  grasshopper  (Knipp  and  Bicker, 
2009); it is possible that the retinal axons also 
require NO-cGMP signaling in order to advance 
successfully.  Given  that  during  the  process  of 
axon guidance, RGCs essentially must migrate 
from  the  retina  to  the  OT,  there  is  at  least  a 
tenuous functional similarity between X. laevis 
axon guidance and grasshopper cell migration.  
  Another  functional  possibility  comes 
from  combining  the  ventral/posterior  NO 
expression  data  with  the  targeting  errors  from 
the functional studies. In the L-NAME treated 
brain  tissue,  the  axons  appear  to  arborize,  or 
branch out, in a more posterior/ventral location 
than  appropriate.  This  widening  appears  to 
extend into the region of maximum NO staining 
observed  in  the  majority  of  the  brain  tissue 
samples.  Perhaps  the  NO  gas  is  acting  as  a 
repulsive  cue  by  preventing  the  axons  from 
extending into the region where the NO gas is 
most heavily expressed; it is only once the axons 
reach  the  tectum  where  other  cues  are  located 
that  arborization  and  innervation  of  the  tissue 
occurs.  This  is  a  similar  function  to  that 
proposed  for  sonic  hedgehog,  a  protein  axon 
guidance  cue  that  is  roughly  expressed  in  the 
region  where  we  observe  maximum  NO 
expression (Gordon et al., 2010). Contrary to the 
pattern of expression of sonic hedgehog, which 
is  not  expressed  outside  of  this  ventral  region 
posterior  to  the  optic  tract,  NO  is  expressed, 
albeit  more  weakly.  Given  that  many  axon 
guidance cues are morphogens, which act based 
on  concentration  gradients,  the  NO  expression 
pattern  could  mean  that  NO  is  functioning  in 
axon  guidance  in  a  morphogenic  fashion  (Zou 
and  Lyuksyutova,  2007).  Other  axon  guidance 
cues  expressed  in  the  diencephalon  that  may 
also  interact  with  NO  include  Slits,  whose 
expression  in  the  ventral  diencephalon  borders 
the optic tract (like that of NO), and Sema3A, 
which is expressed in the forebrain (Atkinson-
Leadbeater et al., 2010, reviewed in Erskine and 
Herrera, 2007). Slits and Sema3a serve a similar 
repulsive function to that hypothesized for NO 
by keeping the axons traveling along the optic 
tract,  which  suggests  the  possibility  of  an 
interaction between NO and these cues. 
  The data from these experiments shows 
that  NOS  is  not  significantly  expressed  in  the 
brain  tissue  until  stage  37  and,  to  these 
researchers’ knowledge, is the first study to stain 
for the presence of the NO gas in X. laevis brain 
tissue  during  the  time  period  in  which  retinal 
axon  guidance  occurs.  The  gas  labeling 
experiments  are  extremely  important,  as  they 
show that the active molecule, NO gas, has an 
appropriate spatiotemporal expression for axon 
guidance.  If  only  NOS  expression  had  been 
examined, definitive conclusions about the role 
of NO could not have been made. The functional 
studies,  although  only  preliminary,  when Page 11 of 12 
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combined with the expression data, suggest an 
important functional role for NO in keeping the 
axons  traveling  appropriately  along  the  optic 
tract and preventing premature arborization and 
targeting.  
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